EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Response to Hall et al .: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness

Heidar Sharafi iD, Didier Jutras-Aswad iD

Addiction · 2024

DOI: 10.1111/add.16434 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Addiction, 2024. Verfasst von Heidar Sharafi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Substance-Related Disorders. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AddictionEarly View LETTER TO THE EDITOR Response to Hall et al.: Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness Heidar Sharafi, Heidar Sharafi orcid.org/0000-0001-9177-9117 Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada Contribution: Conceptualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorDidier Jutras-Aswad, Corresponding Author Didier Jutras-Aswad [email protected] orcid.org/0000-0002-8474-508X Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada Correspondence Didier Jutras-Aswad, CHUM Research Centre, 900 St-Denis, Viger Tower, Room R05.746, Montréal, QC, Canada H2X 1P1. Email: [email protected] Contribution: Conceptualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this author Heidar Sharafi, Heidar Sharafi orcid.org/0000-0001-9177-9117 Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada Contribution: Conceptualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this authorDidier Jutras-Aswad, Corresponding Author Didier Jutras-Aswad [email protected] orcid.org/0000-0002-8474-508X Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada Correspondence Didier Jutras-Aswad, CHUM Research Centre, 900 St-Denis, Viger Tower, Room R05.746, Montréal, QC, Canada H2X 1P1. Email: [email protected] Contribution: Conceptualization (equal), Writing - original draft (equal), Writing - review & editing (equal)Search for more papers by this author First published: 10 January 2024 https://doi.org/10.1111/add.16434Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Hall W, Darke S, Farrell M. Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders? Addiction. 2024. https://doi.org/10.1111/add.16416 10.1111/add.16416 PubMedGoogle Scholar 2Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, et al. Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: a systematic review and meta-analysis of randomized placebo-controlled trials. Addiction. 2024. PMID: Available at: https://doi.org/10.1111/add.16347 10.1111/add.16347 Web of Science®Google Scholar 3Konstenius M, Jayaram-Lindstrom N, Guterstam J, Beck O, Philips B, Franck J. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction. 2014; 109: 440–449. 10.1111/add.12369 PubMedWeb of Science®Google Scholar 4Nadine E, Adrian D, Michelle H, Robert A, Rebecca M, Raimondo B, et al. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. BMJ Open. 2018; 8:e020723. PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System StimulantsSubstance-Related DisordersHumansCost-Benefit AnalysisAmphetaminePrescriptions

Stichwörter der Autor:innen

Amphetamineamphetamine-related disordersdependencemethamphetaminepharmacotherapypsychostimulantstimulant use disordertreatment

Substanzen

Central Nervous System StimulantsAmphetamine

Autor:innen und Institutionen

  • Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
  • Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada.

ORCID-Profile: Heidar Sharafi, Didier Jutras-Aswad

Zitieren

APA

Sharafi, H., & Jutras-Aswad, D. (2024). Response to Hall et al .: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness. Addiction. https://doi.org/10.1111/add.16434

Vancouver

Sharafi H, Jutras-Aswad D. Response to Hall et al .: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness. Addiction. 2024. doi:10.1111/add.16434

BibTeX
@article{Sharafi2024,
  author = {Sharafi, Heidar and Jutras-Aswad, Didier},
  title = {Response to Hall et al .: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness},
  journal = {Addiction},
  year = {2024},
  doi = {10.1111/add.16434}
}
Kostenlos starten →